AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17320026 — intervention group
Group type: EXPERIMENTAL
Intervention: Surrogate markers for PMO treatments
Number of subjects: 0
Study 17320026 — intervention group
Group type: EXPERIMENTAL
Intervention: Integration of surrogate markers in PMO management
Number of subjects: 0
Study 15311423 — intervention group
Group type: EXPERIMENTAL
Intervention: Public health training on high blood pressure control and obesity reduction
Number of subjects: 400
Study 15311423 — intervention group
Group type: COMPARATOR
Intervention: No training
Number of subjects: 400
Study 11771636 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental condition where the interviewer contradicted information provided by participants
Number of subjects: 0
Study 11771636 — intervention group
Group type: EXPERIMENTAL
Intervention: Adult participants
Number of subjects: 0
Study 11771636 — intervention group
Group type: EXPERIMENTAL
Intervention: Preschool participants
Number of subjects: 0
Study 9433573 — intervention group
Group type: EXPERIMENTAL
Intervention: Prior segregation analysis
Number of subjects: 200
Study 9433573 — intervention group
Group type: COMPARATOR
Intervention: Linkage only approach
Number of subjects: 200
Study 9433573 — intervention group
Group type: EXPERIMENTAL
Intervention: All replicates
Number of subjects: 200
Study 9433573 — intervention group
Group type: EXPERIMENTAL
Intervention: Replicates with a major gene found
Number of subjects: 200
Study 8356499 — intervention group
Group type: EXPERIMENTAL
Intervention: Verres needle technique
Number of subjects: 252
Study 8356499 — intervention group
Group type: COMPARATOR
Intervention: Direct insertion technique
Number of subjects: 252
Study 3306292 — intervention group
Group type: EXPERIMENTAL
Intervention: Org OD 14 (2.5 mg/day for 12 weeks)
Number of subjects: 60
Study 3306292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31365441 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 100
Study 31365441 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher BMI and hemoglobin A1C levels
Number of subjects: 100
Study 31365441 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender differences in smoking history
Number of subjects: 100
Study 31365441 — intervention group
Group type: EXPERIMENTAL
Intervention: Age group comparison (50 years or younger vs older than 50 years)
Number of subjects: 100
Study 31365441 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol levels
Number of subjects: 100
Study 28803691 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical lavender oil ointment
Number of subjects: 48
Study 28803691 — intervention group
Group type: COMPARATOR
Intervention: Night wrist orthotic and placebo ointment
Number of subjects: 48
Study 27243899 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobility Program (MP) - assisted ambulation up to twice daily with a behavioral strategy to encourage mobility.
Number of subjects: 100
Study 27243899 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC) - received twice-daily visits.
Number of subjects: 100
Study 26580884 — intervention group
Group type: EXPERIMENTAL
Intervention: Dual-wavelength laser system (595-nm PDL combined with 1,064-nm Nd:YAG laser)
Number of subjects: 16
Study 23472071 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% vaginal tenofovir gel
Number of subjects: 868
Study 19661957 — intervention group
Group type: EXPERIMENTAL
Intervention: Instructor-led intervention (ILI)
Number of subjects: 60
Study 19661957 — intervention group
Group type: COMPARATOR
Intervention: Self-help (SH)
Number of subjects: 60
Study 18801383 — intervention group
Group type: EXPERIMENTAL
Intervention: Aligned Fourier phase in different regions of the face frequency spectrum
Number of subjects: 0
Study 18801383 — intervention group
Group type: COMPARATOR
Intervention: Fixed signal‐to‐noise ratio of phase alignment within a contiguous range of face frequencies
Number of subjects: 0
Study 15872361 — intervention group
Group type: EXPERIMENTAL
Intervention: Postacquisition subtraction of a low-noise random coincidence estimate
Number of subjects: 0
Study 15872361 — intervention group
Group type: COMPARATOR
Intervention: Real-time subtraction of a delayed coincidence channel
Number of subjects: 0
Study 12809830 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin 600 mg per day
Number of subjects: 380
Study 12809830 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin 1200 mg per day
Number of subjects: 380
Study 12809830 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 380
Study 12809830 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin (both doses)
Number of subjects: 380
Study 10793453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylene oxide (EO) sterilization management practices in medical institutions
Number of subjects: 120
Study 10793453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylene oxide (EO) sterilization activities in hospitals
Number of subjects: 120
Study 10793453 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethylene oxide (EO) sterilization activities in clinics
Number of subjects: 120
Study 10793453 — intervention group
Group type: EXPERIMENTAL
Intervention: Management and work methods with EO
Number of subjects: 120
Study 10793453 — intervention group
Group type: EXPERIMENTAL
Intervention: Appointment of an occupational health physician
Number of subjects: 120
Study 9238887 — intervention group
Group type: EXPERIMENTAL
Intervention: Dentrust toothbrush
Number of subjects: 93
Study 9238887 — intervention group
Group type: COMPARATOR
Intervention: Oral-B toothbrush
Number of subjects: 93
Study 1346268 — intervention group
Group type: EXPERIMENTAL
Intervention: Epanolol (200 mg daily)
Number of subjects: 114
Study 1346268 — intervention group
Group type: COMPARATOR
Intervention: Metoprolol (200 mg daily)
Number of subjects: 114
Study 6384637 — intervention group
Group type: EXPERIMENTAL
Intervention: Pindolol eye drops
Number of subjects: 0
Study 6384637 — intervention group
Group type: COMPARATOR
Intervention: Timolol
Number of subjects: 0
Study 30072789 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct composite resin restorations
Number of subjects: 0
Study 30072789 — intervention group
Group type: COMPARATOR
Intervention: Indirect composite resin restorations
Number of subjects: 0
Study 30072789 — intervention group
Group type: EXPERIMENTAL
Intervention: Inlay restorations
Number of subjects: 0
Study 30072789 — intervention group
Group type: EXPERIMENTAL
Intervention: Onlay restorations
Number of subjects: 0
Study 27473613 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute after-school physical activity club offered 3 days a week
Number of subjects: 1519
Study 27473613 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-minute after-school physical activity club
Number of subjects: 1519
Study 25147013 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneohydrotherapy (18 days of treatment including Kneipp therapy, walking in a mineral water pool, massage, and bathing in a mineral water tub)
Number of subjects: 99
Study 25147013 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 99
Study 22264996 — intervention group
Group type: EXPERIMENTAL
Intervention: LPS (0.4 ng/kg)
Number of subjects: 11
Study 20347063 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional words (taboo and negative) presented from the right speaker
Number of subjects: 0
Study 20347063 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional words (taboo and negative) presented from the left speaker
Number of subjects: 0
Study 20347063 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive words
Number of subjects: 0
Study 20347063 — intervention group
Group type: COMPARATOR
Intervention: Lateralized beep detection
Number of subjects: 0
Study 18381581 — intervention group
Group type: EXPERIMENTAL
Intervention: Growth Hormone (GH)
Number of subjects: 43
Study 18381581 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 43
Study 15642562 — intervention group
Group type: EXPERIMENTAL
Intervention: Niacin
Number of subjects: 8341
Study 15642562 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8341
Study 12558207 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoeducational intervention (intervention brochure)
Number of subjects: 2966
Study 12558207 — intervention group
Group type: COMPARATOR
Intervention: Standard invitation (control group)
Number of subjects: 2966
Study 11693946 — intervention group
Group type: EXPERIMENTAL
Intervention: Gas chromatography‐mass spectrometry (GC‐MS) analysis
Number of subjects: 99
Study 11693946 — intervention group
Group type: EXPERIMENTAL
Intervention: Enzyme-linked immunosorbent assay (ELISA) for mercapturate metabolic product
Number of subjects: 99
Study 11693946 — intervention group
Group type: EXPERIMENTAL
Intervention: Triazine in water ELISA
Number of subjects: 99
Study 8925544 — intervention group
Group type: EXPERIMENTAL
Intervention: Heparan sulphate (100 mg/day for 3-4 months)
Number of subjects: 102
Study 1531468 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic salpingostomy
Number of subjects: 0
Study 1531468 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 0
Study 1531468 — intervention group
Group type: EXPERIMENTAL
Intervention: Conservative surgical approach
Number of subjects: 0
Study 6418441 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (2 mg 4-times daily)
Number of subjects: 31
Study 31332603 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided subclavian vein catheterization
Number of subjects: 170
Study 31332603 — intervention group
Group type: COMPARATOR
Intervention: Fluoroscopy-guided subclavian vein catheterization
Number of subjects: 170
Study 28145769 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline peer victimization
Number of subjects: 121
Study 28145769 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower social support from classmates
Number of subjects: 121
Study 28145769 — intervention group
Group type: EXPERIMENTAL
Intervention: Parental anxiety severity
Number of subjects: 121
Study 26363305 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session intervention
Number of subjects: 99
Study 26363305 — intervention group
Group type: EXPERIMENTAL
Intervention: Six sessions of cognitive therapy
Number of subjects: 99
Study 26363305 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavior therapy
Number of subjects: 99
Study 26363305 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational therapy
Number of subjects: 99
Study 24232449 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention hospitals (targeted behavioral intervention)
Number of subjects: 557
Study 24232449 — intervention group
Group type: COMPARATOR
Intervention: Control hospitals (no intervention)
Number of subjects: 557
Study 24232449 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients arriving by ambulance
Number of subjects: 557
Study 24232449 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with severe strokes
Number of subjects: 557
Study 24232449 — intervention group
Group type: EXPERIMENTAL
Intervention: Postintervention period
Number of subjects: 557
Study 22246780 — intervention group
Group type: EXPERIMENTAL
Intervention: Not exposed to SHS for 6 months (Group 1)
Number of subjects: 498
Study 22246780 — intervention group
Group type: COMPARATOR
Intervention: Exposed to SHS for 6 months (Group 2)
Number of subjects: 498
Study 20304772 — intervention group
Group type: EXPERIMENTAL
Intervention: Airway clearance therapy (ACT)
Number of subjects: 153
Study 17559610 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted arthritis self-management programme with added exercise component
Number of subjects: 120
Study 17559610 — intervention group
Group type: COMPARATOR
Intervention: Joint protective practice
Number of subjects: 120
Study 10727589 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisone (1 or 2 mg/kg body weight)
Number of subjects: 224
Study 10727589 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 224
Study 9403265 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine sugar ointment (P-1, P-2, P-3)
Number of subjects: 0
Study 9403265 — intervention group
Group type: COMPARATOR
Intervention: Commercially available product (UP)
Number of subjects: 0
Study 9403265 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine sugar ointment (P-3)
Number of subjects: 0
Study 9403265 — intervention group
Group type: EXPERIMENTAL
Intervention: Povidone-iodine sugar ointment (P-1, P-2)
Number of subjects: 0
Study 1438106 — intervention group
Group type: COMPARATOR
Intervention: Advice Only (AO)
Number of subjects: 1286
Study 1438106 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling Intervention (CI)
Number of subjects: 1286
Study 1438106 — intervention group
Group type: EXPERIMENTAL
Intervention: Counseling plus Nicotine-Containing Gum (CI+NCG)
Number of subjects: 1286
Study 3800432 — intervention group
Group type: COMPARATOR
Intervention: 0 ppm nitrogen dioxide (NO2)
Number of subjects: 21
Study 3800432 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 ppm nitrogen dioxide (NO2)
Number of subjects: 21
Study 3800432 — intervention group
Group type: EXPERIMENTAL
Intervention: 1.0 ppm nitrogen dioxide (NO2)
Number of subjects: 21
Study 3800432 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 ppm nitrogen dioxide (NO2)
Number of subjects: 21
Study 30290905 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide (200-400 mg, orally on days 1-28) during induction and maintenance therapy.
Number of subjects: 536
Study 30290905 — intervention group
Group type: EXPERIMENTAL
Intervention: Thalidomide maintenance therapy (50 mg, orally, daily).
Number of subjects: 536
Study 30290905 — intervention group
Group type: COMPARATOR
Intervention: Interferon alfa (3 × 10^6 international units, subcutaneously, three times weekly) during maintenance therapy.
Number of subjects: 536
Study 26777774 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil 400 mg
Number of subjects: 57
Study 26777774 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study 24503927 — intervention group
Group type: EXPERIMENTAL
Intervention: Triflusal
Number of subjects: 441
Study 24503927 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 441
Study 22801271 — intervention group
Group type: EXPERIMENTAL
Intervention: Test formulation (national made atorvastatin)
Number of subjects: 24
Study 22801271 — intervention group
Group type: COMPARATOR
Intervention: Reference formulation (imported atorvastatin)
Number of subjects: 24
Study 20430288 — intervention group
Group type: EXPERIMENTAL
Intervention: TCM acupuncture
Number of subjects: 51
Study 20430288 — intervention group
Group type: COMPARATOR
Intervention: Shallow needle (sham) acupuncture
Number of subjects: 51
Study 18339796 — intervention group
Group type: EXPERIMENTAL
Intervention: Lateral raise
Number of subjects: 12
Study 18339796 — intervention group
Group type: EXPERIMENTAL
Intervention: Upright row
Number of subjects: 12
Study 18339796 — intervention group
Group type: EXPERIMENTAL
Intervention: Shrug
Number of subjects: 12
Study 15735110 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily multiple micronutrient supplement (DMM)
Number of subjects: 265
Study 15735110 — intervention group
Group type: COMPARATOR
Intervention: Daily placebo supplement (P)
Number of subjects: 265
Study 15735110 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple micronutrient supplement 1 day of the week and placebo on other days (WMM)
Number of subjects: 265
Study 15735110 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily iron supplement (DI)
Number of subjects: 265
Study 12908647 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational training by a work co-ordinator
Number of subjects: 1037
Study 12908647 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 1037
Study 10745611 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous collagen hemostasis device
Number of subjects: 165
Study 8916595 — intervention group
Group type: EXPERIMENTAL
Intervention: Pilocarpine 1% and Clonidine 0.125% combination
Number of subjects: 0
Study 8916595 — intervention group
Group type: COMPARATOR
Intervention: Pilocarpine 1%
Number of subjects: 0
Study 8916595 — intervention group
Group type: COMPARATOR
Intervention: Clonidine 0.125%
Number of subjects: 0
Study 8916595 — intervention group
Group type: COMPARATOR
Intervention: Timolol 0.5%
Number of subjects: 0
Study 1873286 — intervention group
Group type: EXPERIMENTAL
Intervention: Mucosal petechiometry
Number of subjects: 0
Study 1873286 — intervention group
Group type: COMPARATOR
Intervention: Template bleeding time
Number of subjects: 0
Study 30624666 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate-reduced, high-protein (CRHP) diet
Number of subjects: 10
Study 30624666 — intervention group
Group type: COMPARATOR
Intervention: Conventional recommended (CR) diet
Number of subjects: 10
Study 28319550 — intervention group
Group type: EXPERIMENTAL
Intervention: Basal infusion (8 mL/h)
Number of subjects: 24
Study 28319550 — intervention group
Group type: COMPARATOR
Intervention: Bolus doses (24 mL every 3 hours for a total of 2 bolus doses)
Number of subjects: 24
Study 25688817 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention (n = 19)
Number of subjects: 35
Study 25688817 — intervention group
Group type: COMPARATOR
Intervention: Control arm (n = 16)
Number of subjects: 35
Study 25688817 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise intervention
Number of subjects: 35
Study 25688817 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 35
Study 24047421 — intervention group
Group type: EXPERIMENTAL
Intervention: Anastrozole 1 mg/day (N=25)
Number of subjects: 90
Study 24047421 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 20 mg/day (N=24)
Number of subjects: 90
Study 24047421 — intervention group
Group type: COMPARATOR
Intervention: Placebo (N=29)
Number of subjects: 90
Study 21861972 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective laser trabeculoplasty (performed a mean of 8.3 ± 4.1 days before injection)
Number of subjects: 31
Study 21861972 — intervention group
Group type: COMPARATOR
Intervention: Intravitreal triamcinolone acetonide injection (control group)
Number of subjects: 31
Study 20007081 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 86
Study 20007081 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 86
Study 17491224 — intervention group
Group type: EXPERIMENTAL
Intervention: 4F catheters
Number of subjects: 177
Study 17491224 — intervention group
Group type: COMPARATOR
Intervention: 6F catheters
Number of subjects: 177
Study 15773821 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster headache (CH)
Number of subjects: 62
Study 15773821 — intervention group
Group type: COMPARATOR
Intervention: Paroxysmal hemicrania (PH)
Number of subjects: 62
Study 12096335 — intervention group
Group type: EXPERIMENTAL
Intervention: IPCfoot
Number of subjects: 78
Study 12096335 — intervention group
Group type: EXPERIMENTAL
Intervention: IPCcalf
Number of subjects: 78
Study 12096335 — intervention group
Group type: EXPERIMENTAL
Intervention: IPCfoot+calf
Number of subjects: 78
Study 12096335 — intervention group
Group type: EXPERIMENTAL
Intervention: IPCfoot+calf and IPCcalf
Number of subjects: 78
Study 9928687 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac (60 mg intramuscular injection)
Number of subjects: 70
Study 9928687 — intervention group
Group type: COMPARATOR
Intervention: Meperidine (100 to 150 mg intramuscular injection based on weight)
Number of subjects: 70
Study 9928687 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketorolac
Number of subjects: 70
Study 9928687 — intervention group
Group type: COMPARATOR
Intervention: Meperidine
Number of subjects: 70
Study 7569822 — intervention group
Group type: EXPERIMENTAL
Intervention: Open coping patterns
Number of subjects: 320
Study 7569822 — intervention group
Group type: EXPERIMENTAL
Intervention: Less social support
Number of subjects: 320
Study 7569822 — intervention group
Group type: EXPERIMENTAL
Intervention: High degree of covert coping (among furniture removers)
Number of subjects: 320
Study 7569822 — intervention group
Group type: EXPERIMENTAL
Intervention: High degree of sleep disturbance
Number of subjects: 320
Study 2373126 — intervention group
Group type: EXPERIMENTAL
Intervention: Felodipine 10 mg
Number of subjects: 9
Study 2373126 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine 10 mg
Number of subjects: 9
Study 7233551 — intervention group
Group type: COMPARATOR
Intervention: Niridazole (7-day treatment)
Number of subjects: 45
Study 7233551 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (1-day treatment, 2 x 30 mg per kg)
Number of subjects: 45
Study 30085011 — intervention group
Group type: EXPERIMENTAL
Intervention: Housing First intervention
Number of subjects: 497
Study 30085011 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational level equal or less than eighth grade
Number of subjects: 497
Study 30085011 — intervention group
Group type: EXPERIMENTAL
Intervention: History of incarceration
Number of subjects: 497
Study 30085011 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance dependence
Number of subjects: 497
Study 30085011 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection drug use during one month prior to recruitment
Number of subjects: 497
Study 30085011 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a psychotic disorder
Number of subjects: 497
Study 30085011 — intervention group
Group type: EXPERIMENTAL
Intervention: Age < 25
Number of subjects: 497
Study 30085011 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood tests performed on 30 participants
Number of subjects: 497
Study 28452603 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy during surgery (Group M)
Number of subjects: 140
Study 28452603 — intervention group
Group type: COMPARATOR
Intervention: No music during surgery (Group C)
Number of subjects: 140
Study 28452603 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy (Group M)
Number of subjects: 140
Study 28452603 — intervention group
Group type: COMPARATOR
Intervention: No music (Group C)
Number of subjects: 140
Study 25622070 — intervention group
Group type: EXPERIMENTAL
Intervention: Low stigma-reducing condition
Number of subjects: 330
Study 25622070 — intervention group
Group type: COMPARATOR
Intervention: High stigma-reducing condition
Number of subjects: 330
Study 24343961 — intervention group
Group type: EXPERIMENTAL
Intervention: Dialectical behaviour therapy (DBT) for 12 months
Number of subjects: 89
Study 21890884 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol in cyclodextrin
Number of subjects: 0
Study 21890884 — intervention group
Group type: COMPARATOR
Intervention: Propofol in lipid
Number of subjects: 0